Affiliation:
1. Sergio E Baranzini Weill Institute of Neuroscience, Department of Neurology. University of California San Francisco, USA
Abstract
Several efforts identifying differential bacterial prevalence in the gut of multiple sclerosis (MS) patients have been reported and many more are underway. While these are critical first steps in determining the involvement of gut microbes in MS pathogenesis, functional assays (both in vitro and in vivo) are needed to explore the mechanisms underlying the observed changes and ultimately implementing interventional strategies to counter severity, progression or even reduce the chance that it develops in the first place.
Funder
National Multiple Sclerosis Society
US Department of Defense
Subject
Clinical Neurology,Neurology